CollPlant Biotechnologies (CLGN) News Today → Healthcare Takes A Big Step Forward With The Help Of AI (From The Bull Report) (Ad) Free CLGN Stock Alerts $6.35 -0.05 (-0.78%) (As of 01:43 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 16 at 7:00 AM | prnewswire.comCOLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FIRST QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATIONMay 12, 2024 | marketbeat.comCollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Sees Large Drop in Short InterestCollPlant Biotechnologies Ltd. (NASDAQ:CLGN - Get Free Report) was the target of a significant decline in short interest in the month of April. As of April 30th, there was short interest totalling 5,800 shares, a decline of 34.8% from the April 15th total of 8,900 shares. Based on an average daily trading volume, of 6,900 shares, the short-interest ratio is currently 0.8 days. Currently, 0.1% of the company's shares are short sold.May 7, 2024 | americanbankingnews.comCollPlant Biotechnologies (NASDAQ:CLGN) Stock Price Down 1.2%April 23, 2024 | finance.yahoo.comCollPlant Biotechnologies (NASDAQ:CLGN) Is In A Strong Position To Grow Its BusinessApril 13, 2024 | marketbeat.comCollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Short Interest Up 33.3% in MarchCollPlant Biotechnologies Ltd. (NASDAQ:CLGN - Get Free Report) saw a large increase in short interest in the month of March. As of March 31st, there was short interest totalling 10,800 shares, an increase of 33.3% from the March 15th total of 8,100 shares. Based on an average daily trading volume, of 8,200 shares, the short-interest ratio is currently 1.3 days. Approximately 0.1% of the shares of the company are short sold.April 8, 2024 | msn.comCollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Q4 2023 Earnings Call TranscriptApril 6, 2024 | seekingalpha.comCollPlant Biotechnologies Ltd. (CLGN) Q4 2023 Earnings Call TranscriptApril 5, 2024 | marketbeat.comCollPlant Biotechnologies (NASDAQ:CLGN) Rating Reiterated by HC WainwrightHC Wainwright reiterated a "buy" rating and issued a $11.00 price objective on shares of CollPlant Biotechnologies in a report on Friday.April 4, 2024 | markets.businessinsider.comCollPlant Biotechnologies FY23 Net Loss NarrowsApril 4, 2024 | msn.comCLGN Stock Earnings: CollPlant Biotechnologies Misses EPS, Misses Revenue for Q4 2023April 4, 2024 | msn.comUS Index Futures Rise, Oil Dips SlightlyApril 4, 2024 | prnewswire.comCOLLPLANT BIOTECHNOLOGIES REPORTS 2023 FULL YEAR FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATEMarch 30, 2024 | marketbeat.comCollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Sees Significant Decrease in Short InterestCollPlant Biotechnologies Ltd. (NASDAQ:CLGN - Get Free Report) was the target of a significant drop in short interest in March. As of March 15th, there was short interest totalling 8,100 shares, a drop of 13.8% from the February 29th total of 9,400 shares. Based on an average daily volume of 11,400 shares, the short-interest ratio is presently 0.7 days. Approximately 0.1% of the company's stock are short sold.March 26, 2024 | finance.yahoo.comCOLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 FULL YEAR FINANCIAL RESULTS AND CONFERENCE CALL INFORMATIONMarch 26, 2024 | marketbeat.comCollPlant Biotechnologies (CLGN) to Release Quarterly Earnings on WednesdayCollPlant Biotechnologies (NASDAQ:CLGN) will be releasing earnings on Wednesday, March 27, Yahoo Finance reports.March 15, 2024 | marketbeat.comCollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Short Interest Up 20.5% in FebruaryCollPlant Biotechnologies Ltd. (NASDAQ:CLGN - Get Free Report) was the recipient of a large increase in short interest in the month of February. As of February 29th, there was short interest totalling 9,400 shares, an increase of 20.5% from the February 14th total of 7,800 shares. Approximately 0.1% of the company's shares are sold short. Based on an average daily trading volume, of 14,000 shares, the days-to-cover ratio is presently 0.7 days.February 15, 2024 | finance.yahoo.comCollPlant Issues Letter to ShareholdersFebruary 15, 2024 | prnewswire.comCollPlant Issues Letter to ShareholdersFebruary 13, 2024 | au.finance.yahoo.comCOLLPLANT BIOTECH. IS-,01 (CPT.MU)January 8, 2024 | finance.yahoo.comCollPlant's CEO to Present at the Octane Aesthetic Tech Forum Conference, in Newport Beach, CaliforniaJanuary 2, 2024 | finance.yahoo.comCollPlant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast ImplantsDecember 2, 2023 | benzinga.comCollPlant Biotechnologies Stock (NASDAQ:CLGN), Analyst Ratings, Price Targets, PredictionsDecember 1, 2023 | finance.yahoo.comCollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Q3 2023 Earnings Call TranscriptNovember 29, 2023 | benzinga.comRecap: CollPlant Biotechnologies Q3 EarningsNovember 29, 2023 | msn.comCollPlant Biotechnologies Non-GAAP EPS of -$0.35November 29, 2023 | finance.yahoo.comCollPlant Biotechnologies Announces Third Quarter Financial Results for 2023November 9, 2023 | finance.yahoo.comCOLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATIONNovember 3, 2023 | finance.yahoo.comWill CollPlant Biotechnologies (NASDAQ:CLGN) Spend Its Cash Wisely?November 1, 2023 | msn.comCollPlant says patent granted in U.S. for photocurable dermal fillerNovember 1, 2023 | finance.yahoo.comCollPlant Biotechnologies Announces Patent Granted in U.S. for Photocurable Dermal FillerOctober 5, 2023 | finance.yahoo.comShareholders in CollPlant Biotechnologies (NASDAQ:CLGN) are in the red if they invested three years agoSeptember 21, 2023 | finance.yahoo.comCollPlant Biotechnologies Joins the United Nations Global Compact, The World's Largest Corporate Sustainability InitiativeSeptember 5, 2023 | finance.yahoo.comCollPlant to Present at the H.C. Wainwright Annual Growth ConferenceAugust 27, 2023 | finance.yahoo.comResults: CollPlant Biotechnologies Ltd. Beat Earnings Expectations And Analysts Now Have New ForecastsAugust 26, 2023 | finance.yahoo.comInvestors Don't See Light At End Of CollPlant Biotechnologies Ltd.'s (NASDAQ:CLGN) TunnelAugust 25, 2023 | finance.yahoo.comCollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Q2 2023 Earnings Call TranscriptAugust 25, 2023 | markets.businessinsider.comCollplant Holdings (CLGN) Gets a Buy from H.C. WainwrightAugust 24, 2023 | seekingalpha.comCollPlant Biotechnologies Non-GAAP EPS of $0.52, revenue of $10.2M beats by $4.86MAugust 24, 2023 | finance.yahoo.comCollPlant Biotechnologies Announces Second Quarter Financial Results For 2023 with Revenues of $10.2 MillionAugust 23, 2023 | benzinga.comPreview: CollPlant Biotechnologies's EarningsAugust 9, 2023 | finance.yahoo.comCOLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 SECOND QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATIONJune 26, 2023 | benzinga.comWhy CollPlant Biotechnologies Stock Is Trading HigherMay 27, 2023 | es-us.finanzas.yahoo.comCollPlant Biotechnologies First Quarter 2023 Earnings: Beats ExpectationsMay 25, 2023 | markets.businessinsider.comH.C. Wainwright Sticks to Their Buy Rating for Collplant Holdings (CLGN)May 24, 2023 | msn.comCollPlant Biotechnologies: Q1 Earnings InsightsMay 24, 2023 | finance.yahoo.comCollPlant Biotechnologies Announces First Quarter Financial Results For 2023 and Provides Corporate UpdateMay 23, 2023 | msn.comEarnings Preview: CollPlant BiotechnologiesMay 2, 2023 | finance.yahoo.comCOLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 FIRST QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATIONApril 4, 2023 | finance.yahoo.comStratasys and CollPlant Unite Technologies to Transform Healthcare with Industrial-Scale Bioprinting of Tissues and OrgansMarch 31, 2023 | finance.yahoo.comCollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Q4 2022 Earnings Call Transcript Get CollPlant Biotechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for CLGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Why Is Gold On a MASSIVE rally? (Ad)Gold has been on a tear this year. The yellow metal has hit an all-time high of $2,4231.29 recently and the rally could be far from over. From central banks to even Costco customers, it seems everyone is buying gold these days. With Wall Street watching the gold space carefully, now is a perfect time to pay attention to this stock. This Little known Company is a uniquely structured for profit CLGN Media Mentions By Week CLGN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CLGN News Sentiment▼1.150.54▲Average Medical News Sentiment CLGN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CLGN Articles This Week▼30▲CLGN Articles Average Week Get CollPlant Biotechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for CLGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Envoy Medical News Today Milestone Scientific News Today Vicarious Surgical News Today ReWalk Robotics News Today Nutriband News Today Inogen News Today Sanara MedTech News Today Tempest Therapeutics News Today CEL-SCI News Today Hookipa Pharma News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CLGN) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldObama’s Forever Term [exposed]Porter & CompanyDems have chosen Biden replacement?Paradigm PressDoes this make you sick?Allegiance GoldHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportWhy Is Gold On a MASSIVE rally? Huge Alerts348 million Americans lives to END as we know it?The Oxford ClubDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CollPlant Biotechnologies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
